Fact CheckerSign in

NCT05603260Completed

Imagery Interventions for Auditory Vocal Hallucinations

An Explorative Experimental Study to Assess the Feasibility, Acceptability and Effectiveness of Imagery Intervention Techniques in the Treatment of Auditory Vocal Hallucinations

Source: ClinicalTrials.gov · Last updated 28 Feb 2024

Brief summary (registry, in English)

This study explores the feasibility, acceptability, and effectiveness of four imagery intervention techniques (metacognitive imagery intervention, imagery rescripting, promoting positive imagery and competing imagery task) for auditory vocal hallucinations using four single case series with an A-B-A within subject design.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
17 Oct 2022
Start date
7 Apr 2022
Primary completion date
10 Feb 2024
Lead sponsor
Hella Janssen
NCT number
NCT05603260

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 7 Apr 2022 to the primary completion date, 10 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any current or previous neurological disorder or organic brain disease.

Other illness

  • Acute confusional state or delirium not caused by the psychotic disorder.

Other

  • Unwillingness to participate
  • Intelligence quotient (IQ) \< 70 estimated by clinician.
  • Current severe substance or alcohol misuse impacting treatment (clinicians assessment).

Who the study is looking for

  • Age 16-65
  • Experiencing subclinical or clinical psychotic auditory vocal hallucinations as confirmed by a clinician and as indicated by an intensity score of 4 or more on subscale 1.3 (perceptual abnormalities) of the Comprehensive Assessment of At Risk Mental States (CAARMS) or as indicated by a score of 3 or more on item P3 (hallucinatory behavior) of the Positive and Negative Syndrome Scale (PANSS).
  • A Diagnostic and Statistical Manual-5 (DSM-5; American Psychiatric Association, 2013) diagnosis in the psychosis spectrum (codes: DSM-5 codes: 297.1; 298.8; 295.40; 295.90; 295.70; 298.8; 298.9) or defined as Ultra High Risk/At Risk Mental State (ARMS or UHR) according to the CAARMS estimated by a clinician.
  • Willing to complete daily monitoring throughout the duration of the study.
  • Willing to be assigned to a specific imagery intervention.
  • Able to attend 3 consecutive weekly session of imagery intervention and during this period 3 online check-ups.
  • Able and willing to sign informed consent

Age in the registry: 16 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Geestelijke Gezondheidszorg Eindhoven (GGzE)
Coordinator of this site? Confirm its status
EindhovenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.